⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12452464 | 0.72 | — | — | |
| SCHEMBL8357271 | 0.68 | — | — | |
| Methylsulfanylmethane SCHEMBL479114 | 0.62 | — | — | |
| Methylsulfanylmethane SCHEMBL8966644 | 0.62 | — | — | |
| Methylsulfanylmethane SCHEMBL1330443 | 0.61 | — | — | |
| Methylsulfanylmethane SCHEMBL5440614 | 0.61 | — | — | |
| Methylsulfanylmethane SCHEMBL1618 | 0.61 | — | — | |
| Methylsulfanylmethane SCHEMBL25351738 | 0.55 | — | — | |
| Methylsulfanylmethane SCHEMBL6940181 | 0.55 | — | — | |
| Methylsulfanylmethane SCHEMBL18834572 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025038758-A1 | IONIC LIQUID SUBSTITUTED POLYSACCHARIDE COMPOUNDS AND METHODS OF USE THEREOF | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2025-02-20 | — | — | WO | claimed |
| WO-2025228975-A1 | PARTICLES, COMPOSITIONS AND METHODS | BioNTech SE (DE) | 2025-11-06 | — | — | WO | disclosed |
| WO-2025109557-A1 | PROCESS FOR THE SYNTHESIS OF MONOESTERS OF ETHYLENEDIAMINETETRAACETIC ACID | Nutrien Ag Solutions (Canada) Inc. (CA) | 2025-05-30 | — | — | WO | disclosed |
| EP-4547197-A1 | METHOD FOR DYEING KERATINOUS MATERIAL COMPRISING THE LEAVE-ON APPLICATION OF A DYE THAT HAS A LOW WATER CONTENT AND COMPRISES C1-C6 ALKOXY SILANE, PIGMENT AND SOLVENT | Henkel AG & Co. KGaA (DE) | 2025-05-07 | — | — | EP | disclosed |
| WO-2025038960-A1 | OLIGONUCLEOTIDES CONTAINING A LIGAND AT AN INTERNAL POSITION | ADARX PHARMACEUTICALS, INC. (US) | 2025-02-20 | — | — | WO | disclosed |
| WO-2025021277-A1 | AGENTS AND METHODS FOR TARGETED DELIVERY OF CYTOKINES TO IMMUNE CELLS | BioNTech SE (DE) | 2025-01-30 | — | — | WO | disclosed |
| US-20250002904-A1 | METHODS AND SYSTEMS FOR GENERATING SEQUENCING LIBRARIES | ADELA, INC. | 2025-01-02 | — | — | US | disclosed |
| EP-4444916-A1 | METHODS AND SYSTEMS FOR GENERATING SEQUENCING LIBRARIES | Adela, Inc. (US) | 2024-10-16 | — | — | EP | disclosed |
| CN-118679267-A | Methods and systems for generating sequencing libraries | 阿黛拉公司 | 2024-09-20 | — | — | CN | disclosed |
| EP-4426289-A1 | AKT3 MODULATORS | Georgiamune Inc. (US) | 2024-09-11 | — | — | EP | disclosed |
| US-20110091500-A1 | Inactivated Live-Attenuated Bluetongue Virus Vaccine | Onderstepoort Biological Products Ltd. (ZA) | 2011-04-21 | — | — | US | disclosed |
| US-20110045999-A1 | IDENTIFICATION OF NOVEL SUBGROUPS OF HIGH-RISK PEDIATRIC PRECURSOR B ACUTE LYMPHOBLASTIC LEUKEMIA, OUTCOME CORRELATIONS AND DIAGNOSTIC AND THERAPEUTIC METHODS RELATED TO SAME | STC.UNM (US) | 2011-02-24 | — | — | US | disclosed |
| US-7842715-B2 | N-benzoyl- and N-benzylpyrrolidin-3-ylamines as histamine-3 antagonists | WYETH LLC (US) | 2010-11-30 | — | — | US | disclosed |
| CN-101489555-A | Nf-kappa | OTSUKA PHARMA CO LTD (JP) | 2009-07-22 | — | — | CN | disclosed |
| US-7498156-B2 | Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components | CARIDIANBCT BIOTECHNOLOGIES, LLC (US) | 2009-03-03 | — | — | US | disclosed |
| WO-2008008374-A2 | CCR2 INHIBITORS AND METHODS OF USE THEREOF | CHEMOCENTRYX, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| US-20070087404-A1 | Poly-beta-peptides from functionalized beta-lactam monomers and antibacterial compositions containing same | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2007-04-19 | — | — | US | disclosed |
| US-4342764-A | Guanidine compounds, pharmaceutical compositions and use | CIBA-GEIGY CORPORATION (US) | 1982-08-03 | — | — | US | disclosed |
| EP-0020304-A1 | Guanidines, process for their preparation, pharmaceutical preparations containing such compounds and their application | CIBA-GEIGY AG (CH) | 1980-12-10 | — | — | EP | disclosed |
| US-4211867-A | ANTISECRETORY AGENTS, HYPOGLYCEMIC AGENTS, ANTIARRHYTHMIA AGENTS | MCNEIL LABORATORIES, INCORPORATED (US) | 1980-07-08 | — | — | US | disclosed |